MangoGen and Orgenesis (NASDAQ:ORGS) announce a collaboration funded by the Canada-Israel Industrial R&D Foundation (CIIRDF) to develop cell therapies to treat diabetes using MangoGen’s baculoviral gene-delivery technology.
MangoGen are pleased to announce that Francois Castconguay has agreed to be a non-executive director on the MangoGen Board. Mr Castconguary retired as CEO of Uniprix in 2015 and will bring 25+ years of executive experience.
MangoGen are pleased to announce the granting of our umbrella patent in the USA (#10,092,602 B2)
(from L-R: Alain Labbe, Paul Plested, Satya Prakash)
MangoGen are pleased to announce the addition of Dr. Bradley Thompson to the MangoGen Board as a Non-Executive Director. Dr Thompson was previously CEO and Co-Founder of Oncolytics Biotech (ONCY) based in Calgary, Canada.
Paul Plested CEO presented MangoGen Pharma at the European Life Sciences CEO Forum in Zurich on February 26th 2018
Paul Plested CEO presented MangoGen Pharma at Biotech and Money World Conference in London on February 6th 2018
Paul Plested CEO presented MangoGen Pharma at Biotech Showcase in San Francisco on January 10th 2018
Paul Plested CEO presented MangoGen Pharma at Life Sciences Summit in New York on November 2nd 2017.
The MangoGen Team back in Jinan City, Shandong Province, with Satya Prakash, President of MangoGen Pharma receiving a prodigious Foreign Expert Award from the Jinan Municipal People’s Government. Alongside Satya are Dr. Paul Plested MangoGen’s CEO, and Dr. Alain Labbe, MangoGen’s Chief Scientific Officer. Also present was Mr. Ma (right of Dr. Labbe), CEO of MaiGao Genetic Coating Co Ltd, MangoGen’s sister organization in China.
MangoGen’s patent is GRANTED in Australia
Paul Plested (CEO) and Satya Prakash (President) presented MangoGen Pharma at the High Level Overseas Talent and Projects Conference in Jinan, Shandong Province, PR China
Paul Plested (CEO) and Alain Labbe (Director of R&D), travel to Jinan to discuss aspects of technology transfer to China.
Top left to right: Meeting the China Team of MaiGao Genetic Company Co Ltd.; Paul and Alain with Mr Ma, Chairman of MaiGao; The New Building; Bottom left to right: Alain and Paul on The Wall; Time Out on The Wall, Alain with Lydia and our guide “Elvis”; The Team discussing new laboratory and production space.
MangoGen employ 2 new Technicians – Rafael and Alain M.
MangoGen awarded an IRAP Grant from the Canadian Government – US$ 140,000 over 16 months
August 21st 2015
MangoGen’s new corporate telephone line is 1-514-800-6872
July 1st 2015
MangoGen’s laboratory, located at the le Centre québécois d’innovation en biotechnologie (CQIB) in Laval, QC., becomes fully operational.
June 1st 2015
MangoGen appoints Dr Alain Labbe as Director of Research & Development.
June 1st 2015
MangoGen is accepted into the full incubation program at the le Centre québécois d’innovation en biotechnologie (CQIB) in Laval, QC.
June 1st 2015
MangoGen complete signing of US$ 1.67 million seed investment from GP HealthCare, Jinan, Shandong Province, PR China.
January 5th 2015
MangoGen enters the pre-incubation program at the le Centre québécois d’innovation en biotechnologie (CQIB) in Laval, QC.